Toll-like receptor 2 (TLR2) plays a major role in innate resistance in the lung against murine mycoplasma

PLoS ONE

Volumn 5, Issue 5, 2010, Pages

  Love, Wees ^a   Dobbs, Nicole ^a   Tabor, Leslie ^a   Simecka, Jerry W ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 6; INTERLEUKIN 6; TLR2 PROTEIN, MOUSE; TLR6 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; CYTOKINE RESPONSE; DENDRITIC CELL; EMBRYO; FEMALE; GENE EXPRESSION; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; INFECTION RESISTANCE; INNATE IMMUNITY; LUNG ALVEOLUS MACROPHAGE; LUNG INFECTION; LUNG LAVAGE; MOUSE; MYCOPLASMA PULMONIS; MYCOPLASMOSIS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; ANIMAL; C57BL MOUSE; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; LUNG; METABOLISM; MICROBIAL VIABILITY; MICROBIOLOGY; MYCOPLASMA;

MURINAE; MUS; MYCOPLASMA; MYCOPLASMA PULMONIS;

ANIMALS; BRONCHOALVEOLAR LAVAGE; GENE EXPRESSION REGULATION; IMMUNITY, INNATE; INTERLEUKIN-6; LUNG; MICE; MICE, INBRED C57BL; MICROBIAL VIABILITY; MYCOPLASMA; MYCOPLASMA INFECTIONS; RNA, MESSENGER; TOLL-LIKE RECEPTOR 1; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 6; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77956281883     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0010739     Document Type: Article

References (51)

1. Krause DC, Taylor-Robinson D (1993) Mycoplasmas which infect humans. In: Maniloff J, McElhaney RN, Finch LR, Baseman JB, eds. Mycoplasmas: Molecular biology and pathogenesis. Washington, D.C.: American Society of Microbiology. pp 417-444.
2. Foy HM (1993) Infections caused by Mycoplasma pneumoniae and possible carrier state in different populations of patients. Clin Infect Dis 17 Suppl 1: S37-46.
3. Foy HM, Kenny GE, Cooney MK, Allan ID (1979) Long-term epidemiology of infections with Mycoplasma pneumoniae. J Infect Dis 139: 681-687.
4. Kraft M, Hamid Q (2006) Mycoplasma in severe asthma. J Allergy Clin Immunol 117: 1197-1198.
5. Weinberger M (2004) Respiratory infections and asthma: current treatment strategies. Drug Discov Today 9: 831-837.
6. Isaacs D, Joshi P (2002) Respiratory infections and asthma. Med J Aust 177 Suppl: S50-51.
7. Simecka JW, Davis JK, Davidson MK, Ross SE, Stadtlander C, et al. (1992) Mycoplasma diseases of animals. In: Maniloff J, McElhaney RN, Finch LR, Baseman JB, eds. Mycoplasmas Molecular biology and pathogenesis. Washington, D.C.: American Society for Microbiology. pp 391-415.
8. Cassell GH (1982) Derrick Edward Award Lecture. The pathogenic potential of mycoplasmas: Mycoplasma pulmonis as a model. Rev Infect Dis 4 Suppl: S18-34.
9. Davis JK, Davidson MK, Schoeb TR, Lindsey JR (1992) Decreased intrapulmonary killing of Mycoplasma pulmonis after short- term exposure to NO2 is associated with damaged alveolar macrophages. Am Rev Respir Dis 145: 406-411.
10. Erb P, Bredt W (1979) Interaction of Mycoplasma pneumoniae with alveolar macrophages: viability of adherent and ingested mycoplasmas. Infect Immun 25: 11-15.
11. Hickman-Davis JM, et al. (1998) Surfactant protein A mediates mycoplasmacidal activity of alveolar macrophages. Am J Physiol Lung Cell Mol Physiol 18.
12. Hodge LM, Simecka JW (2002) Role of upper and lower respiratory tract immunity in resistance to Mycoplasma respiratory disease. J Infect Dis 186: 290-294.
13. Jones H, Tabor L, Sun X, Woolard M, Simecka J (2002) Depletion of CD8+ T cells exacerbates CD4+ Th cell associated inflammatory lesions during murine mycoplasma respiratory disease. Journal of Immunology 168: 3493-3501.
14. Jones HP, Simecka JW (2003) T lymphocyte responses are critical determinants in the pathogenesis and resistance to Mycoplasma respiratory disease. Front Biosci 8: D930-945.
15. Into T, Kiura K, Yasuda M, Kataoka H, Inoue N, et al. (2004) Stimulation of human Toll-like receptor (TLR) 2 and TLR6 with membrane lipoproteins of Mycoplasma fermentans induces apoptotic cell death after NF-kappa B activation. Cell Microbiol 6: 187-199.
16. Shimizu T (2005) A dipalmitoylated lipoprotein from Mycoplasma pneumoniae Activates NF-kB through TLR1, TLR2 and TLR6. Journal of Immunology 175: 4641-4646.
17. Shimizu T, Kida Y, Kuwano K (2004) Lipid-associated membrane proteins of Mycoplasma fermentans and M. penetrans activate human immunodeficiency virus long-terminal repeats through Toll-like receptors. Immunology 113: 121-129.
18. Shimizu T, Kida Y, Kuwano K (2008) A triacylated lipoprotein from Mycoplasma genitalium activates NF-kappaB through Toll-like receptor 1 (TLR1) and TLR2. Infect Immun 76: 3672-3678.
19. He J, You X, Zeng Y, Yu M, Zuo L, et al. (2009) Mycoplasma genitalium-derived lipid-associated membrane proteins activate NF-kappaB through toll-like receptors 1, 2, and 6 and CD14 in a MyD88-dependent pathway. Clin Vaccine Immunol 16: 1750-1757.
20. Chu HW, Jeyaseelan S, Rino JG, Voelker DR, Wexler RB, et al. (2005) TLR2 signaling is critical for Mycoplasma pneumoniae-induced airway mucin expression. J Immunol 174: 5713-5719.
21. Wu Q, Martin RJ, Rino JG, Jeyaseelan S, Breed R, et al. (2007) A deficient TLR2 signaling promotes airway mucin production in Mycoplasma pneumoniaeinfected allergic mice. Am J Physiol Lung Cell Mol Physiol 292: L1064-1072.
22. Wu Q, Martin RJ, Lafasto S, Efaw BJ, Rino JG, et al. (2008) Toll-like receptor 2 down-regulation in established mouse allergic lungs contributes to decreased mycoplasma clearance. Am J Respir Crit Care Med 177: 720-729.
23. Brightbill HD, Libraty DH, Krutzik SR, Yang RB, Belisle JT, et al. (1999) Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 285: 732-736.
24. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, et al. (2006) Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311: 1770-1773.
25. Noss EH, Pai RK, Sellati TJ, Radolf JD, Belisle J, et al. (2001) Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis. J Immunol 167: 910-918.
26. Fuse ET, Tateda K, Kikuchi Y, Matsumoto T, Gondaira F, et al. (2007) Role of Toll-like receptor 2 in recognition of Legionella pneumophila in a murine pneumonia model. J Med Microbiol 56: 305-312.
27. Powell JD, Boodoo S, Horton MR (2004) Identification of the molecular mechanism by which TLR ligation and IFN-gamma synergize to induce MIG. Clin Dev Immunol 11: 77-85.
28. Zabel BA, Ohyama T, Zuniga L, Kim JY, Johnston B, et al. (2006) Chemokinelike receptor 1 expression by macrophages in vivo: regulation by TGF-beta and TLR ligands. Exp Hematol 34: 1106-1114.
29. Davis JK, Delozier KM, Asa DK, Minion FC, Cassell GH (1980) Interactions between murine alveolar macrophages and Mycoplasma pulmonis in vitro. Infect Immun 29: 590-599.
30. Hickman-Davis JM, Michalek SM, Gibbs-Erwin J, Lindsey JR (1997) Depletion of alveolar macrophages exacerbates respiratory mycoplasmosis in mycoplasmaresistant C57BL mice but not mycoplasma-susceptible C3H mice. Infect Immun 65: 2278-2282.
31. Shimizu T, Kida Y, Kuwano K (2005) A dipalmitoylated lipoprotein from Mycoplasma pneumoniae activates NF-kappa B through TLR1, TLR2, and TLR6. J Immunol 175: 4641-4646.
32. Faulkner CB, Simecka JW, Davidson MK, Davis JK, Schoeb TR, et al. (1995) Gene expression and production of tumor necrosis factor alpha, interleukin 1, interleukin 6, and gamma interferon in C3H/HeN and C57BL/6N mice in acute Mycoplasma pulmonis disease. Infection & Immunity 63: 4084-4090.
33. Fulton SA, Reba SM, Pai RK, Pennini M, Torres M, et al. (2004) Inhibition of major histocompatibility complex II expression and antigen processing in murine alveolar macrophages by Mycobacterium bovis BCG and the 19-kilodalton mycobacterial lipoprotein. Infect Immun 72: 2101-2110.
34. Mitsunari M, Yoshida S, Shoji T, Tsukihara S, Iwabe T, et al. (2006) Macrophage-activating lipopeptide-2 induces cyclooxygenase-2 and prostaglandin E(2) via toll-like receptor 2 in human placental trophoblast cells. J Reprod Immunol 72: 46-59.
35. Triantafilou M, Gamper FG, Haston RM, Mouratis MA, Morath S, et al. (2006) Membrane sorting of toll-like receptor (TLR)-2/6 and TLR2/1 heterodimers at the cell surface determines heterotypic associations with CD36 and intracellular targeting. J Biol Chem 281: 31002-31011.
36. Takeuchi O, Sato S, Horiuchi T, Hoshino K, Takeda K, et al. (2002) Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J Immunol 169: 10-14.
37. Omueti KO, Beyer JM, Johnson CM, Lyle EA, Tapping RI (2005) Domain exchange between human toll-like receptors 1 and 6 reveals a region required for lipopeptide discrimination. J Biol Chem 280: 36616-36625.
38. Takeuchi O, Kawai T, Muhlradt PF, Morr M, Radolf JD, et al. (2001) Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int Immunol 13: 933-940.
39. Wooten RM, Ma Y, Yoder RA, Brown JP, Weis JH, et al. (2002) Toll-like receptor 2 plays a pivotal role in host defense and inflammatory response to Borrelia burgdorferi. Vector Borne Zoonotic Dis 2: 275-278.
40. Becker S, Fenton MJ, Soukup JM (2002) Involvement of microbial components and toll-like receptors 2 and 4 in cytokine responses to air pollution particles. Am J Respir Cell Mol Biol 27: 611-618.
41. Echchannaoui H, Leib SL, Neumann U, Landmann RM (2007) Adjuvant TACE inhibitor treatment improves the outcome of TLR22/2 mice with experimental pneumococcal meningitis. BMC Infect Dis 7: 25.
42. Arko-Mensah J, Julian E, Singh M, Fernandez C (2007) TLR2 but not TLR4 signalling is critically involved in the inhibition of IFN-gamma-induced killing of mycobacteria by murine macrophages. Scand J Immunol 65: 148-157.
43. Doyle SE, O'Connell RM, Miranda GA, Vaidya SA, Chow EK, et al. (2004) Toll-like receptors induce a phagocytic gene program through p38. J Exp Med 199: 81-90.
44. Woolard MD, Hudig D, Tabor L, Ivey JA, Simecka JW (2005) NK cells in gamma-interferon-deficient mice suppress lung innate immunity against Mycoplasma spp. Infect Immun 73: 6742-6751.
45. Prebeck S, Kirschning C, Durr S, da Costa C, Donath B, et al. (2001) Predominant role of toll-like receptor 2 versus 4 in Chlamydia pneumoniae-induced activation of dendritic cells. J Immunol 167: 3316-3323.
46. Redecke V, Hacker H, Datta SK, Fermin A, Pitha PM, et al. (2004) Cutting edge: activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma. J Immunol 172: 2739-2743.
47. Patel M, Xu D, Kewin P, Choo-Kang B, McSharry C, et al. (2005) TLR2 agonist ameliorates established allergic airway inflammation by promoting Th1 response and not via regulatory T cells. J Immunol 174: 7558-7563.
48. Davidson MK, Davis JK, Lindsey JR, Cassell GH (1988) Clearance of different strains of Mycoplasma pulmonis from the respiratory tract of C3H/HeN mice. Infect Immun 56: 2163-2168.
49. Sato M, Iwakabe K, Kimura S, Nishimura T (1999) Functional skewing of bone marrow-derived dendritic cells by Th1- or Th2-inducing cytokines. Immunol Lett 67: 63-68.
50. Kruisbeek A (1999) Isolation and fractionation of mononuclear cell populations. In: Coligan JE, Kruisbeek A, Margulies D, Shevach E, Strober W, eds. Current protocols in immunology. New YorkN.Y.: John Wiley&Sons, Inc. pp 3.1.1-3.1.5.
51. Davis JK, Davidson M, Schoeb TR (1991) Murine respiratory mycoplasmosis: a model to study effects of oxidants. Res Rep Health Eff Inst. pp 1-29; discussion 31-43.